Arthritis Research & Therapy

official impact factor 4.36

Letter

Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease

Miguel A Gonzalez-Gay1,2*, Carlos Gonzalez-Juanatey3, Tomas R Vazquez-Rodriguez2, Javier Martin4 and Javier Llorca1,5,6

Author Affiliations

1 MAG-G and JL are senior authors

2 Division of Rheumatology, Hospital Xeral Calde, c) Dr Ochoa s/n, 27004, Lugo, Spain

3 Division of Cardiology, Hospital Xeral Calde, c) Dr Ochoa s/n, 27004, Lugo, Spain

4 Consejo Superior de Investigaciones Cientificas, Avenida del Conocimiento s/n, 18100, Armilla, Granada, Spain

5 Division of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, Avda. Cardenal Herrera Oria s/n, 39011, Santander, Spain

6 CIBER Epidemiología y Salud Pública (CIBERESP), Spain

For all author emails, please log on.

Arthritis Research & Therapy 2008, 10:403 doi:10.1186/ar2409

Published: 16 May 2008

First paragraph (this article has no abstract)

We read with interest the editorial by Veldhuijzen van Zanten and Kitas [1], in which they consider whether carotid artery intima-media thickness (IMT) – a surrogate marker of atherosclerosis – might be a good predictor of future cardiovascular events in patients with rheumatoid arthritis (RA). They state that it remains an open question, because no long-term studies have documented such an association in patients with RA. We are pleased to provide the readers of this journal with an answer to this question.